NCT04911972 is a clinical trial of Functional muscle transfer in Sarcoma, sponsored by NHS Greater Glasgow and Clyde.

Who is sponsoring NCT04911972?

NCT04911972 is sponsored by NHS Greater Glasgow and Clyde.

What drugs are being tested in NCT04911972?

Interventions in NCT04911972: Functional muscle transfer.

What condition does NCT04911972 study?

NCT04911972 studies Sarcoma, Muscle Tumor, Muscle Loss.

Is NCT04911972 still recruiting?

NCT04911972 is currently completed. Last updated 13 December 2021.

Last reviewed 2021-12-13 · How we verify

NCT04911972

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Functional Muscle Transfers in Lower Limb Sarcoma: 3D Gait Analysis and Environmental Simulation

Completed Last updated 13 December 2021

What this trial tests

trial testing Functional muscle transfer in Sarcoma in 27 participants. Completed in 1 July 2021.

Timeline

1 January 2016

Primary endpoint
1 July 2021

1 July 2021

Quick facts

Lead sponsor	NHS Greater Glasgow and Clyde
Status	Completed
Study type	OBSERVATIONAL
Enrollment	27
Start date	1 January 2016
Primary completion	1 July 2021
Estimated completion	1 July 2021
Sites	1 location across United Kingdom

Drugs / interventions tested

Functional muscle transfer

Conditions studied

Sarcoma — all drugs for Sarcoma →
Muscle Tumor — all drugs for Muscle Tumor →
Muscle Loss — all drugs for Muscle Loss →

Sponsor

NHS Greater Glasgow and Clyde — full company profile →

Who can join

Adults 18 to 95, any sex, with Sarcoma or Muscle Tumor. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to assess patient's function after functional limb restoring surgery, performed after ablative tumour surgery or trauma. However, there are no studies as yet providing objective proof of the recovery of function after this type of surgery. This study will use 3D Gait Analysis, Environmental simulation and Patient Reported Outcome Measures to compare patients with function restoring surgery against patients without function restoring surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Sarcoma

Currently open trials in the same condition.

NCT07402577 — Brief Title Mechanisms of Cancer-Related Pain and Opioid Use Among Adolescents and Young Adult Sarcoma Survivors: Pilot · recruiting
NCT07501026 — Preoperative Spatially Fractionated Radiation Therapy (SFRT) in Soft Tissue Sarcoma (neoSFRT-SARC) · Phase 2 · recruiting
NCT07359911 — Effect of A Multimodal Exercise Intervention on Chemotherapy Uptake in Newly Diagnosed Pediatric and AYA Sarcoma Patient · NA · recruiting
NCT07410676 — EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors · Phase 1, PHASE2 · recruiting
NCT07222735 — Hypofractionated Radiation in Combination With B7-H3-CAR T Cells for Pediatric Patients With Relapsed/Refractory Sarcoma · Phase 1 · recruiting

Other NHS Greater Glasgow and Clyde trials

Trials by the same sponsor.

NCT07403890 — Rewiring the Brain-Immune Axis for Chronic Pain Using Transcranial Magnetic Stimulation in Psoriatic Arthritis · NA · not yet recruiting
NCT07372508 — Glasgow Low-dose CT and AI-based Diagnostics to Case Find Lung Cancer and Other Cardio-respiratory Long-term Conditions · NA · not yet recruiting
NCT07391280 — Strategy for EArly Recognition of Cancer, COPD & Heart Failure in the Emergency Department · NA · not yet recruiting
NCT07048184 — Sarcoma Surgery Wound Complications Comparing Usual Versus Negative Pressure Dressing · Phase 2 · not yet recruiting
NCT06786936 — Evaluating the Role of IL-17 as an Orchestrator of Peripheral-central Cross Talk in Depressive Symptoms · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04911972 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by NHS Greater Glasgow and Clyde
Last refreshed: 13 December 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04911972.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing